Global Health Limited has scheduled its 22nd Annual General Meeting (AGM) for Wednesday, September 16, 2026. The meeting will be conducted through Video Conferencing or Other Audio Visual Means in compliance with Ministry of Corporate Affairs and SEBI circulars.

Key Agenda Items

The ordinary business for the AGM includes the consideration and adoption of the Audited Standalone and Consolidated Financial Statements for the financial year ended March 31, 2026. The Board of Directors also recommends a final dividend of ₹0.50 per equity share for FY26.

Additionally, shareholders will vote on the re-election of Mr. Pankaj Sahni as a Director. He retires by rotation and is eligible for re-election. The special business involves approving the remuneration of ₹12.50 Lakhs (excluding taxes) to M/s. Ramanath Iyer & Co. as Cost Auditors for FY27.

Dividend Details

The record date for determining dividend entitlement is August 14, 2026. The dividend is proposed to be paid within 30 days from the date of declaration, subject to member approval. The company will withhold tax at prescribed rates based on the residential status and documentation provided by shareholders.

E-Voting and Participation

Remote e-voting will be available from Saturday, September 12, 2026, at 9:00 am to Tuesday, September 15, 2026, at 5:00 pm. Shareholders holding shares as on the cut-off date of Thursday, September 10, 2026, are eligible to vote. The facility is provided by National Securities Depository Limited (NSDL).

Members can join the AGM via VC/OAVM 15 minutes before and after the scheduled start time. Participation is limited to 1,000 members on a first-come, first-served basis, excluding large shareholders holding 2% or more, promoters, institutional investors, and key managerial personnel.

Global Health Limited will host a virtual analyst meeting on August 21, 2026, as part of its ongoing engagement with institutional investors. The company disclosed the schedule in a filing dated August 18, 2026, confirming that management will participate in a one-to-one session with First Ray Capital based in Singapore.

The interaction is structured as a standard investor dialogue rather than a broad conference call. Global Health Limited emphasised that no unpublished price-sensitive information (UPSI) is proposed to be shared during the discussion. This aligns with regulatory norms requiring equal information access for all market participants.

Meeting details

The specific parameters of the scheduled engagement are outlined below:

Rahul Ranjan, Company Secretary and Compliance Officer at Global Health Limited, signed the intimation. He noted that the schedule remains subject to change in the event of unforeseen circumstances involving the analysts, investors, or the company.

Regulatory context

The disclosure was made pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. This regulation mandates timely disclosure of material events and ensures transparency in interactions between listed entities and financial intermediaries.

Global Health Limited listed this update under reference number GHL/2026-27/EXCH/41. The filing was directed to the listing departments of both BSE Limited and the National Stock Exchange of India Limited.